Andy Pike

Company: AstraZeneca
Job title: Project leader, DMPK, Oncology R&D
Seminars:
Workshop B: Enhancing Oral Bioavailability of Bivalent Degraders to Improve Patient Exposure & Maximise Therapeutic Efficacy 1:00 pm - 3:00 pm
day: Workshop B